# US 2019/0375705 A1 · Tyramine containing hydroxycinnamic acid amide derivatives and methods of use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0375705 A1
- Document ID: US20190375705A1
- Status: Published application
- Kind: A1
- Application number: 16/510,005
- Filed: 2019-07-12
- Published: 2019-12-12
- Earliest claimed: 2018-01-10
- Assignees: Brightseed, Inc.
- Applicants: Brightseed, Inc.
- Inventors: Lee Heil CHAE; Jessica Leigh OCHOA; Dennis SOLAS
- Web page: https://patentgrep.com/patent/US20190375705A1

## CPC

- A61K 31/165: having aromatic rings, e.g. colchicine, atenolol, progabide
- C07C 235/34: having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- A61K 36/81: Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K 36/8962: Allium, e.g. garden onion, leek, garlic or chives
- A61P 3/06: Antihyperlipidemics
- C07D 215/227: only one oxygen atom which is attached in position 2
- C07D 239/80: Oxygen atoms
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Tyramine containing hydroxycinnamic acid amide derivatives are provided as are methods of using the same in modulating metabolism and addressing the underlying pathogenesis of metabolic disorders, such as nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and type II diabetes mellitus.

## Claims

### Claim 1

A compound having the structure of Formula I, or an isomer, salt, homodimer, heterodimer, or conjugate thereof:
wherein
each occurrence of X is independently C or N;
Z is —CR6— or —SO2—
R1 is an —OH, —OCH2CH2R7, or —NHR8 group, or R1 together with R5 form a 6-membered substituted heterocycloalkyl ring,
R2 and R3 are independently a hydrogen or —CH2CH2R7 group, or R2 and R3 together form a five- or six-membered heterocycloalkyl ring;
R4 is a hydrogen or —CH2CH2R7 group;
R5 is present or absent and when present is a substituent on one or more ring atoms and for each occurrence is independently a halo, hydroxy, alkyl, substituted alkyl, alkoxy, substituted sulfonyl, carboxyl ester, amino, substituted amino, cyano, aryl, substituted aryl, cycloalkyl, heteroaryl, substituted heteroaryl;
R6 is H2, oxo, substituted alkyl, spirocycloalkyl or spiroheterocycloalkyl;
R7 is a hydrogen, hydroxy, alkyl, substituted alkyl, alkoxy, substituted sulfonyl, carboxyl ester, amino, substituted amino, cyano, aryl, substituted aryl, cycloalkyl, heteroaryl, substituted heteroaryl;
R8 is substituted sulfonyl, substituted alkyl, carboxyl ester or aminocarbonyl; and
the dashed bond is present or absent.

### Claim 2 (depends on 1)

The compound of claim 1, wherein said compound has the structure of Formula II:
wherein
R1 is —OCH2CH2R7, and
R7 is a hydrogen, hydroxy, alkyl, substituted alkyl, alkoxy, substituted sulfonyl, carboxyl ester, amino, substituted amino, cyano, aryl, substituted aryl, cycloalkyl, heteroaryl, substituted heteroaryl.

### Claim 3 (depends on 1)

The compound of claim 1, wherein said compound has the structure of Formula III:
wherein
R2 is —CH2CH2R7, and
R7 is a hydrogen, hydroxy, alkyl, substituted alkyl, alkoxy, substituted sulfonyl, carboxyl ester, amino, substituted amino, cyano, aryl, substituted aryl, cycloalkyl, heteroaryl, substituted heteroaryl.

### Claim 4 (depends on 1)

The compound of claim 1, wherein said compound has the structure of Formula IV:
wherein
R3is —CH2CH2R7, and
R7 is a hydrogen, hydroxy, alkyl, substituted alkyl, alkoxy, substituted sulfonyl, carboxyl ester, amino, substituted amino, cyano, aryl, substituted aryl, cycloalkyl, heteroaryl, substituted heteroaryl.

### Claim 5 (depends on 1)

The compound of claim 1, wherein said compound has the structure of Formula V:
wherein
R4 is —CH2CH2R7, and
R7 is a hydrogen, hydroxy, alkyl, substituted alkyl, alkoxy, substituted sulfonyl, carboxyl ester, amino, substituted amino, cyano, aryl, substituted aryl, cycloalkyl, heteroaryl, substituted heteroaryl.

### Claim 6 (depends on 1)

The compound of claim 1, wherein said compound has the structure of Formula VI:
wherein
R5 is a substituent on one or more ring atoms and for each occurrence is independently a halo, hydroxy, alkyl, substituted alkyl, alkoxy, substituted sulfonyl, carboxyl ester, amino, substituted amino, cyano, aryl, substituted aryl, cycloalkyl, heteroaryl, substituted heteroaryl;

### Claim 7 (depends on 1)

The compound of claim 1, wherein said compound has the structure of Formula VII:
wherein each occurrence of X is independently C or N.

### Claim 8 (depends on 1)

The compound of claim 1, wherein said compound has the structure of Formula VIII:
wherein
Z is —CR6— or —SO2—;
R6 is H2, substituted alkyl, spirocycloalkyl or spiroheterocycloalkyl; and
the dashed bond is present or absent.

### Claim 9 (depends on 1)

The compound of claim 1, wherein said compound has the structure of Formula VIX:
wherein
R1 is an —NHR8 group, or R1 together with R5 form a 6-membered substituted heterocycloalkyl ring;
R8 is substituted sulfonyl, substituted alkyl, carboxyl ester or aminocarbonyl.

### Claim 10 (depends on 1)

A dietary supplement, food ingredient or additive, a medical food, nutraceutical or pharmaceutical composition comprising a compound of claim 1.

### Claim 11 (depends on 10)

A method for modulating metabolism comprising administering to a subject in need thereof an effective amount of a dietary supplement, food ingredient or additive, a medical food, nutraceutical or pharmaceutical composition of claim 10.

### Claim 12 (depends on 11)

The method of claim 11, wherein said effective amount improves HNF4α activity, insulin-like growth factor levels, blood sugar levels, insulin levels, HbA1C levels, C peptide levels, triglyceride levels, free fatty acid levels, blood uric acid levels, microalbuminuria levels, glucose transporter expression, adiponectin levels, total serum cholesterol levels, high density lipoprotein levels, low density lipoprotein levels or a combination thereof.

### Claim 13 (depends on 11)

The method of claim 11, wherein the subject has or is at risk of developing a metabolic disorder.

### Claim 14 (depends on 13)

The method of claim 13, wherein the metabolic disorder comprises insulin resistance, hyperglycemia, type II diabetes mellitus, obesity, glucose intolerance, hypercholesterolemia, hyperlipoproteinemia, dyslipidemia, hyperinsulinemia, atherosclerotic disease, coronary artery disease, metabolic syndrome, or hypertension.
